Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Times Interest Earned (2017 - 2024)

Neurocrine Biosciences' Times Interest Earned history spans 8 years, with the latest figure at $90.27 for Q1 2024.

  • For Q1 2024, Times Interest Earned rose 186.95% year-over-year to $90.27; the TTM value through Dec 2024 reached $518.64, up 850.87%, while the annual FY2023 figure was $54.54, 55.53% up from the prior year.
  • Times Interest Earned reached $90.27 in Q1 2024 per NBIX's latest filing, down from $136.64 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $136.64 in Q4 2023 to a low of -$103.82 in Q1 2023.
  • Average Times Interest Earned over 5 years is $31.65, with a median of $9.23 recorded in 2020.
  • Peak YoY movement for Times Interest Earned: surged 1809.09% in 2022, then tumbled 8807.33% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at $9.21 in 2020, then tumbled by 159.75% to -$5.5 in 2021, then soared by 1809.09% to $94.0 in 2022, then surged by 45.36% to $136.64 in 2023, then plummeted by 33.93% to $90.27 in 2024.
  • Per Business Quant, the three most recent readings for NBIX's Times Interest Earned are $90.27 (Q1 2024), $136.64 (Q4 2023), and $128.36 (Q3 2023).